Interviews
News Flash
Canadian Competition Bureau to monitor Johnson & Johnson for Guidant acquisition
03 Sep '05
2 min read
New Jersey based health care products maker Johnson & Johnson has been advised by the Canadian Competition Bureau that it has decided not to take any action at this time on the Company's proposed acquisition of Guidant Corporation in relation to markets affected by that proposed acquisition. The Competition Bureau conducted an extensive review under the provisions of the Canadian Competition Act.
The Canadian Competition Bureau has advised Johnson & Johnson, however, that it will monitor developments in certain Canadian markets related to the acquisition over the three-year period provided under the Competition Act.
In addition, in response to the Competition Bureau's specific concerns relating to the market for steerable guidewires in Canada, Johnson & Johnson will be offering for sale its Cordis coronary steerable guidewires business there. An Offering Memorandum in that regard will be made available to interested purchasers subject to appropriate confidentiality conditions.
The world's most comprehensive & broadly based health care products producer Johnson & Johnson is also offers that products related services, for the consumer, pharmaceutical, and medical devices and diagnostics markets. The more than 200 Johnson & Johnson operating companies employ approximately 113,800 men and women in 57 countries and sell products throughout the world.
Cardiovascular medical products leader Guidant's devices help patients with heart disease return to active and productive lives. They provide physicians with leading-edge technologies for improved patient management and clinical outcomes. And they have created a culture in which employees, investors and our communities share in our success.
The Canadian Competition Bureau has advised Johnson & Johnson, however, that it will monitor developments in certain Canadian markets related to the acquisition over the three-year period provided under the Competition Act.
In addition, in response to the Competition Bureau's specific concerns relating to the market for steerable guidewires in Canada, Johnson & Johnson will be offering for sale its Cordis coronary steerable guidewires business there. An Offering Memorandum in that regard will be made available to interested purchasers subject to appropriate confidentiality conditions.
The world's most comprehensive & broadly based health care products producer Johnson & Johnson is also offers that products related services, for the consumer, pharmaceutical, and medical devices and diagnostics markets. The more than 200 Johnson & Johnson operating companies employ approximately 113,800 men and women in 57 countries and sell products throughout the world.
Cardiovascular medical products leader Guidant's devices help patients with heart disease return to active and productive lives. They provide physicians with leading-edge technologies for improved patient management and clinical outcomes. And they have created a culture in which employees, investors and our communities share in our success.
Johnson & Johnson
Popular News
Leave your Comments
Editor’s Pick
Esteemed Clients
-Ltd..jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Thermore (Far East) Ltd.")
.jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Telangana State Industrial Infrastructure Corporation Limited (TSllC Ltd)")
.jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Taiwan Textile Federation (TTF)")
